Design, Manufacture & Deliver Safer, More Efficacious, Globally Accessible Treatments for Solid Tumors, Leveraging γδT Mechanisms As newly published data show the first Gamma Delta T cell therapy's clinical efficacy in patients, the race to market for the first allogeneic and solid tumor-targeting γδT has begun.
26-28 July 2022